Sign in
OBX Stock Price, Chart, Stats & News
Obsidian Therapeutics Inc.
Save
Obsidian Therapeutics Inc. (OBX) does not currently pay a dividend.
18.48M
Market cap
–
Current P/E
–
Forward P/E
OBX chart
1M
3M
1Y
5Y
Loading chart...
About
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors.
Similar securities
Based on sector and market capitalization
Report issue